Clinical management of infectious cerebral vasculitides

Expert Review of Neurotherapeutics

Volumn 16, Issue 2, 2016, Pages 205-221

  Carod Artal, Francisco Javier ^a,b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

Cerebral vasculitis; infectious disease; infectious vasculitides; Lyme disease; mycotic aneurysm; stroke; syphilis; VZV vasculopathy

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ALBENDAZOLE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CEFTRIAXONE; CORTICOSTEROID; DOXYCYCLINE; ETHAMBUTOL; FLUCONAZOLE; FLUCYTOSINE; ISONIAZID; ITRACONAZOLE; PENICILLIN G; PRAZIQUANTEL; PROBENECID; PROCAINE PENICILLIN; PYRAZINAMIDE; PYRROLE DERIVATIVE; RIFAMPICIN; TISSUE PLASMINOGEN ACTIVATOR; VORICONAZOLE; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT;

ASPERGILLOSIS; BLOOD CLOT LYSIS; BRAIN ANGIOGRAPHY; BRAIN BIOPSY; BRAIN INFECTION; BRAIN VASCULITIS; CANDIDIASIS; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CRYPTOCOCCAL MENINGITIS; CYSTICERCOSIS; DOPPLER ECHOGRAPHY; ENDOVASCULAR SURGERY; FUNGAL MENINGITIS; HERPES ZOSTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYME DISEASE; MAGNETIC RESONANCE ANGIOGRAPHY; MYCOTIC ANEURYSM; NEUROCYSTICERCOSIS; NEUROIMAGING; NEUROSCHISTOSOMIASIS; NEUROSYPHILIS; NONHUMAN; REVIEW; TUBERCULOUS MENINGITIS; VASCULAR DISEASE; ANEURYSM, INFECTED; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; COMPLICATION; DISEASE MANAGEMENT; ENCEPHALITIS, VARICELLA ZOSTER; FIBRINOLYTIC THERAPY; HIV INFECTIONS; INTRACRANIAL ANEURYSM; LYME NEUROBORRELIOSIS; MENINGITIS, BACTERIAL; TUBERCULOSIS, MENINGEAL; VASCULITIS, CENTRAL NERVOUS SYSTEM; X-RAY COMPUTED TOMOGRAPHY;

ADRENAL CORTEX HORMONES; ANEURYSM, INFECTED; ANTI-INFECTIVE AGENTS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; CEREBRAL ANGIOGRAPHY; DISEASE MANAGEMENT; ENCEPHALITIS, VARICELLA ZOSTER; ENDOVASCULAR PROCEDURES; HIV INFECTIONS; HUMANS; INTRACRANIAL ANEURYSM; LYME NEUROBORRELIOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MENINGITIS, BACTERIAL; NEUROCYSTICERCOSIS; NEUROSYPHILIS; PLATELET AGGREGATION INHIBITORS; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, MENINGEAL; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 84958114314     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2015.1134321     Document Type: Review

References (93)

1. Fugate JE, Lyons JL, Thakur KT, et al. Infectious causes of stroke. Lancet Infect Dis. 2014;14:869-880.
2. Katchanov J, Siebert E, Klingebiel R, et al. Infectious vasculopathy of intracranial large- and medium-sized vessels in neurological intensive care unit: a clinico-radiological study. Neurocrit Care. 2010;12:369-374.
3. Schut ES, Lucas MJ, Brouwer MC, et al. Cerebral infarction in adults with bacterial meningitis. Neurocrit Care. 2012;16:421-427.
4. Schut ES, Brouwer MC, de Gans J, et al. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis. Neurology. 2009;73:1988-1995.
5. Carod-Artal FJ. Strokes caused by infection in the tropics. Rev Neurol. 2007;44:755-763.
6. Sico JJ, Chang CH, So-Armah K, et al. HIV status and the risk of ischemic stroke among men. Neurology. 2015;84:1933-1940.
7. Valcour V, Chalermchai T, Sailasuta N, et al. Central nervous system viral invasion and inflammation during acute HIV infection. J Infect Dis. 2012;206:275-282.
8. Gutierrez J, Glenn M, Isaacson RS, et al. Thinning of the arterial media layer as a possible preclinical stage in HIV vasculopathy: a pilot study. Stroke. 2012;43:1156-1158.
9. Gutierrez J, Ortiz G. HIV-AIDS patients with HIV vasculopathy and VZV vasculitis. Clin Neuroradiol. 2011;21:145-151.
10. Tipping B, de Villiers L, Candy S, et al. Stroke caused by human immunodeficiency virus-associated intracranial large-vessel aneurysmal vasculopathy. Arch Neurol. 2006;63:1640-1642.
11. Kossorotoff M, Touze E, Godon-Hardy S, et al. Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology. 2006;66:1121-1122.
12. Newsome SD, Nath A. Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J Neurovirol. 2009;15:288-291.
13. Teo S, Raha D, Warren D, et al. Central nervous systemimmune reconstitution inflammatory syndrome presenting as varicella zoster virus-mediated vasculitis causing stroke. Int J STD AIDS. 2014;25:683-685.
14. Anderson AM, Fountain JA, Green SB, et al. Human immunodeficiency virus-associated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution. J Neurovirol. 2010;16:179-184.
15. Braun KP, Bulder MM, Chabrier S, et al. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischemic stroke. Brain. 2009;132:544-557.
16. Sreenivasan N, Basit S, Wohlfahrt J, et al. The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study. PLoS One. 2013;8: e69156.
17. Kang J-H, Ho J-D, Chen Y-H, et al. Increased risk of stroke after a herpes zoster attacks: a population-based followup study. Stroke. 2009;40:3443-3448.
18. Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology. 2010;74:792-797.
19. Breuer J, Pacou M, Gauthier A, et al. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014;82:206-212.
20. Langan SM, Minassian C, Smeeth L, et al. Risk of stroke following herpes zoster: a self-controlled case-series study. Clin Infect Dis. 2014;58:1497-1503.
21. Nagel MA, Gilden D. The relationship between herpes zoster and stroke. Curr Neurol Neurosci Rep. 2015;15:16.
22. Matsuo K, Uozumi Y, Miyamoto H, et al. Varicella-zoster vasculitis presenting with cerebellar hemorrhage. J Stroke Cerebrovasc Dis. 2015;6:e153-5.
23. Bhayani N, Ranade P, Clark NM, et al. Varicella-zoster virus and cerebral aneurysm: case report and review of the literature. Clin Infect Dis. 2008;47:e1-3.
24. Liberman AL, Nagel MA, Hurley MC, et al. Rapid development of nine cerebral aneurysms in varicella zoster virus vasculopathy. Neurology. 2014;82:2139-2141.
25. Dalton CM, Jager HR, Lossef NA, et al. Neurological picture. Varicella zoster and intracranial dolichoectasia in a late adult cancer survivor. J Neurol Neurosurg Psychiatry. 2008;79:573.
26. Nagel MA, Bennett JL, Khmeleva N, et al. Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology. 2013;80:2017-2021.
27. De Broucker T, Verollet D, Schoindre Y, et al. Cerebral vasculitis with aneurysms caused by varicella-zoster virus infection during AIDS: a new clinicoangiographical syndrome. Rev Neurol (Paris). 2008;164:61-71.
28. Nagel MA, Traktinsky I, Azarhk Y, et al. Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology. 2011;77:364-370.
29. Lee SM, Park HS, Choi JH, et al. Ruptured mycotic aneurysm of the distal middle cerebral artery manifesting as subacute subdural hematoma. J Cerebrovasc Endovasc Neurosurg. 2013;15:235-240.
30. Ferro JM, Fonseca AC, Infective endocarditis. Handb Clin Neurol. 2014;119:75-91.
31. Novy E, Sonneville R, Mazighi M, et al. Neurological complications of infective endocarditis: new breakthroughs in diagnosis and management. Med Mal Infect. 2013;43:443-450.
32. Kannoth S, Thomas SV, Nair S, et al. Proposed diagnostic criteria for intracranial infectious aneurysms. J Neurol Neurosurg Psychiatry. 2008;79:943-946.
33. Habib G, Hoen B, Tornos P, et al., ESCCommittee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J. 2009;30:2369-2413.
34. Artal C. Infections of the spinal cord. In: Garcia MJC, editor CNS infections: a clinical approach. London: Springer-Verlag; 2014. p. 181-210.
35. Lammie GA, Hewlett RH, Schoeman JF, et al. Tuberculous cerebrovascular disease: a review. J Infec. 2009;59:156-166.
36. Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J Neurol Sci. 2011;303:22-30.
37. Topakian R, Stieglbauer K, Nussbaumer K, et al. Cerebral vasculitis and stroke in Lyme neuroborreliosis. Two cases reports and review of current knowledge. Cerebrovasc Dis. 2008;26:455-461.
38. Wittwer B, Pelletier S, Ducrocq X, et al. Cerebrovascular events in Lyme neuroborreliosis. J Stroke Cerebrovasc Dis. 2015;24:1671-1678.
39. Back T, Grünig S, Winter Y, et al. Neuroborreliosis-associated cerebral vasculitis: long-term outcome and healthrelated quality of life. J Neurol. 2013;260:1569-1575.
40. Lebas A, Toulgoat F, Saliou G, et al. Stroke due to Lyme neuroborreliosis: changes in vessel wall contrast enhancement. J Neuroimaging. 2012;22:210-212.
41. Kurian M, Pereira VM, Vargas MI, et al. Stroke-like phenomena revealing multifocal cerebral vasculitis in pediatric Lyme neuroborreliosis. J Child Neurol. 2015;30:1226-1229.
42. Kohns M, Karenfort M, Schaper J, et al. Transient ischaemic attack in a 5-year old girl due to focal vasculitis in neuroborreliosis. Cerebrovasc Dis. 2013;35:184-185.
43. Adamaszek M, Heinrich A, Rang A, et al. Cerebral sinuvenous thrombosis associated with Lyme neuroborreliosis. J Neurol. 2010;257:481-483.
44. Berger JR, Dean D. Neurosyphilis. Handb Clin Neurol. 2014;121:1461-1472.
45. Bucher JB, Golden MR, Heald AE, et al. Stroke in a patient with human immunodeficiency virus and syphilis treated with penicillin and antiretroviral therapy. Sex Transm Dis. 2011;38:442-444.
46. Liu LL, Zheng WH, Tong ML, et al. Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. J Neurol Sci. 2012;317:35-39.
47. Cordato DJ, Djekic S, Taneja SR, et al. Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005-09). J Clin Neurosci. 2013;20:943-947.
48. Al-Shammari NE, El-Beltagi AH, Al-Far SA, et al. Syphilitic arteritis involving the origin of the cervical internal carotid artery. Neurosciences (Riyadh). 2010;15:122-125.
49. Bäuerle J, Zitzmann A, Egger K, et al. The great imitatorstill today! A case of meningovascular syphilis affecting the posterior circulation. J Stroke Cerebrovasc Dis. 2015;24:e1-3.
50. Yin-Dan Y, Wen-Ke H, Li-Feng G. Meningovascular syphilis with basilar artery occlusion: case report and literature review. Neurol India. 2014;62:213-214.
51. Nagappa M, Sinha S, Taly AB, et al. Neurosyphilis: MRI features and their phenotypic correlation in a cohort of 35 patients from a tertiary care university hospital. Neuroradiology. 2013;55:379-388.
52. Starkey J, Moritani T, Kirby P, MRI of CNS fungal infections: review of aspergillosis to histoplasmosis and everything in between. Clin Neuroradiol. 2014;24:217-230.
53. Okazaki T, Shiraishi S, Iwasa N, et al. Extended voriconazole therapy and long term survival of a patient with invasive central aspergillosis causing stroke. Rinsho Shinkeigaku. 2015;55:472-477.
54. Cachia D, Singh C, Tetzlaff MT, et al. Middle cerebral artery territory infarct due to Cryptococcus infectionstitle: An uncommon indication for cerebrospinal fluid analysis in stroke patients. Diagn Cytopathol. 2015;43:632-634.
55. Rosario M, Song SX, McCullough LD. An unusual case of stroke. Neurologist. 2012;18:229-232.
56. Nguyen FN, Kar JK, Zakaria A, et al. Isolated central nervous system histoplasmosis presenting with ischemic pontine stroke and meningitis in an immune-competent patient. JAMA Neurol. 2013;70:638-641.
57. Carod-Artal F, Venturini M, Gomes E, et al. Chronic central nervous system histoplasmosis in an immunocompetent patient. Neurologia. 2008;23:263-268.
58. Del Brutto OH. Neurocysticercosis. Handbook Clin Neurol. 2014;121:1445-1459.
59. Marquez JM, Arauz A. Cerebrovascular complications of neurocysticercosis. Neurologist. 2012;18:17-22.
60. Viola GM, White AC Jr, Serpa JA. Hemorrhagic cerebrovascular events and neurocysticercosis: a case report and review of the literature. Am J Trop Med Hyg. 2011;84:402-405.
61. Carod Artal FJ. Cerebral and spinal schistosomiasis. Curr Neurol Neurosci Rep. 2012;12:666-674.
62. Jaureguiberry S, Ansart S, Perez L, et al. Acute neuroschistosomiasis: two cases associated with cerebral vasculitis. Am J Trop Med Hyg. 2007;76:964-966.
63. Caumes E, Vidailhet M. Acute neuroschistosomiasis: a cerebral vasculitis to treat with corticosteroids not praziquantel. J Travel Med. 2010;17:359.
64. Carod-Artal FJ. Neuroschistosomiasis. Expert Rev Anti Infect Ther. 2010;8:1307-1318.
65. Carod-Artal FJ, Wichmann O, Farrar J, et al. Neurological complications of dengue virus infection. Lancet Neurol. 2013;12:906-919.
66. Carod-Artal FJ. American trypanosomiasis. Handb Clin Neurol. 2013;114:103-123.
67. Bentley P, Quadri F, Wild EJ, et al. Vasculitic presentation of Staphylococcal meningitis. Arch Neurol. 2007;64:1788-1789.
68. Ay S, Tur BS, Kutlay S. Cerebral infarct due to meningovascular neurobrucellosis: a case report. Int J Infect Dis. 2010;14(Suppl 3):e202-4.
69. Inan AS, Ceran N, Erdem I, et al. Neurobrucellosis with transient ischemic attack, vasculopathic changes, intracerebral granulomas and basal ganglia infarction: a case report. J Med Case Rep. 2010;4:340.
70. Klein M, Koedel U, Pfefferkorn T, et al. Arterial cerebrovascular complications in 94 adults with acute bacterial meningitis. Crit Care. 2011;15:R281.
71. Geretti AM, Tsakiroglou M. HIV: new drugs, new guidelines. Curr Opin Infect Dis. 2014;27:545-553.
72. Nagel MA, Gilden D. Neurological complications of VZV reactivation. Curr Opin Neurol. 2014;27:356-360.
73. Johnson MD, Perfect JR. Use of antifungal combination therapy: agents, order, and timing. Curr Fungal Infect Rep. 2010;4:87-95.
74. Perfect JR, Dismukes WE, Dromer F, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50:291-322.
75. Garcia HH, Gonzales I, Lescano AG, et al., Cysticercosis working group in Peru. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014;14:687-695.
76. Bartolini L, Gentilomo C, Sartori S, et al. Varicella and stroke in children: good outcome without steroids. Clin Appl Thromb Hemost. 2011;17:E127-30.
77. Brouwer MC, Heckenberg SG, de Gans J, et al. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology. 2010;75:1533-1539.
78. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev. 2008;1: CD002244.
79. Thwaites GE, Macmullen-Price J, Chau TTH, et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol. 2007;6:230-236.
80. Thwaites G, Fisher M, Hemingway C, et al. British infection society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in aduts anjd children. J Infect. 2009;59:167-187.
81. Bouldin A, Pinter JD. Resolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisone. J Child Neurol. 2006;21:1064-1067.
82. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870-947.
83. Chow F, Regan S, Feske S, et al. Comparison of ischemic stroke incidence in HIV-infected patients and non-HIV infected patients in a US health care system. J Acquir Immune Defic Syndr. 2012;60:351-358.
84. Misra UK, Kalita J, Nair PP, Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial. J Neurol Sci. 2010;293:12-17.
85. Taqui A, Koffman L, Hui F, et al. Intra-arterial vasodilator therapy for parainfectious cerebral vasospasm. J Neurol Sci. 2014;340:225-229.
86. Gujjar AR, Srikanth SG, Umameheshwara Rao GS. HHH regime for arteritis secondary to TB meningitis: a prospective randomized study. Neurocrit Care. 2009;10:313-317.
87. Han JH, Lee CC, Crupi RS. Meningovascular syphilis and improvement with tissue plasminogen activator (t-PA). Am J Emerg Med. 2004;22:426-427.
88. Feng W, Caplan M, Matheus MG, et al. Meningovascular syphilis with fatal vertebrobasilar occlusion. Am J Med Sci. 2009;338:169-171.
89. Peters PJ, Harrison T, Lennox JL. A dangerous dilemma: management of infectious intracranial aneurysms complicating endocarditis. Lancet Infect Dis. 2006;6:742-748.
90. Saraf R, Limaye U. Ruptured intracranial tubercular infectious aneurysm secondary to a tuberculoma and its endovascular management. Br J Neurosurg. 2013;27:243-245.
91. Gilden D, White T, Khmeleva N, et al. Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis. Neurology. 2015;84:1948-1955.
92. Kotter I, Henes JC, Wagner AD, et al. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature. Clin Exp Rheumatol. 2012;30(1 Suppl 70):S114-29.
93. Carod Artal FJ. Meningococcal meningitis: vaccination outbreak response and epidemiological changes in the African meningitis belt. Int Health. 2015;7:226-227.